Replies to post #794 on Verastem (VSTM)

[powerwalker]

Given the pipeline and the recent gains and volume, is VSTM a candidate for an early buy-out, like Verona's too early sale to Merck?

Does anyone have any thoughts? Mine are that Merck might be in the weeds again.